TRENTO, Italy and SAN DIEGO, Jan. 23, 2018 -- Aquafil and Genomatica have announced a multi-year agreement to create sustainable caprolactam, a key ingredient to producing 100 percent sustainable nylon. The collaboration aims to develop a commercially-advantageous bioprocess (Genomatica’s GENO CPL™ process) to make caprolactam using plant-based renewable ingredients, rather than the crude oil-derived materials traditionally used by the nylon industry.
|
||||||||
Enabling more sustainable nylon products
Used in a variety of nylon-based products including carpets and apparel, caprolactam has a worldwide market of over five million tons per year. Genomatica’s GENO CPL™ process aims to provide an environmentally-friendly way to make caprolactam with better economics, including for smaller-scale plants. Additionally, it will enable licensees and their customers to differentiate themselves by offering a more sustainable bio-based product whose performance will be fully comparable with nylon made from crude oil-derived caprolactam, and which will not require any machine or process adjustments by the nylon supply chain. Genomatica is the licensor of the GENO CPLTM process.
A photo accompanying this announcement is available at:
http://www.globenewswire.com/NewsRoom/AttachmentNg/b5115b74-282c-400e-b629-dc1de1369a44
Aquafil is a leading producer of nylon yarn and launched the ECONYL® Regeneration System in 2011 to produce nylon made from 100 percent regenerated waste. A large and growing number of globally recognized sportswear, fashion, luxury and carpet brands choose ECONYL® as the sustainable ingredient for their product. Like the ECONYL® process, the GENO CPL™ process eliminates the significant amount of by-products common to most crude oil-derived caprolactam production, and will allow producers to diversify their sources in terms of raw material.
Opportunities for chemical producers, product makers and brands
Genomatica invites other leaders in the nylon value chain to join its bio-nylon program – and Aquafil encourages further collaboration with supply chain partners. By joining the program, companies ranging from chemical producers and product makers to agriculture companies and major brands can engage, influence priorities and gain access to Genomatica’s technologies and supply of bio-based chemicals.
Supporting quotes
“As proven by the success of ECONYL®, consumers and manufacturers look forward to opportunities to play an active role in the circular economy. We aim to be a leader of sustainability for nylon, and we are excited by the opportunity to be the first to bring the benefits of this new technology to our customers, which is perfectly in line with our commitment to creating sustainable products,” said Giulio Bonazzi, Chairman and CEO of Aquafil. “Genomatica brings the technology, innovation and track record to help us achieve this.”
“Visionary companies like Aquafil are delighting customers and gaining market share through more sustainable products,” said Christophe Schilling, CEO of Genomatica. “This is another example of Genomatica applying the power of biology to rethink how widely-used chemicals can be made a better way. Just as we’ve surpassed key milestones for our commercial GENO BDO process and were named winner of the ICIS Innovation Award for our new naturally sourced butylene glycol, we now aim to bring biotechnology innovation to enable better nylon products.”
About Aquafil
Since 1969, Aquafil has been one of the leading players, both in Italy and globally, in the production of polyamide 6 (nylon 6). The Aquafil Group has a presence in eight countries on three continents, employing more than 2,700 staff at 15 plants located in Italy, Germany, Scotland, Slovenia, Croatia, the USA, Thailand and China. For more information, visit www.aquafil.com.
About Genomatica
Genomatica is a widely-recognized leader in bioengineering. It develops biobased process technologies that enable a better way to produce widely-used chemicals, from alternative feedstocks, with better economics, sustainability and performance. Genomatica has earned widespread acclaim for its technology and commercialization achievements. Awards include the Kirkpatrick Award, for “the most noteworthy chemical engineering technology commercialized in the world” and the ICIS Innovation Award. To learn more, see www.genomatica.com.
For more information:
For Aquafil: Maria Giovanna Sandrini, [email protected]
For Genomatica: Steve Weiss, [email protected], +1.858.210.4424


Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Washington Post Publisher Will Lewis Steps Down After Layoffs
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 



